Aumet, a Saudi-founded healthcare procurement startup, has raised $12 million in Series A funding to scale its artificial intelligence-enabled pharmaceutical supply chain platform across the Gulf Cooperation Council and emerging markets. The platform connects pharmacies, distributors, manufacturers, and hospitals into a cohesive network delivering real-time inventory visibility and procurement automation.
- Aumet operates a B2B platform with over 12,000 pharmacy partners processing $1B in merchandise volume.
- The solution provides AI-driven decision support and real-time inventory visibility across the supply chain.
- Expansion targets GCC markets including Saudi Arabia, Jordan, Egypt, and Oman.
Market signal
Aumet’s recent $12 million Series A raise highlights rising global and regional interest in digitizing healthcare procurement systems, especially within the Gulf Cooperation Council where supply chain complexities have traditionally hindered efficiency. The investment reflects a broader trend towards embedding AI into operational infrastructure beyond clinical applications, directly addressing the fragmented workflows and siloed supplier networks prevalent in pharmaceutical procurement.
With over 12,000 pharmacies integrated on its platform generating upwards of $1 billion in transaction volume, Aumet demonstrates significant traction in digital healthcare marketplaces. This funding is poised to accelerate geographic and functional expansion in emerging markets, meeting surging demands for automation, transparency, and agility in medical supply chains amid ongoing cost pressures and pandemic-era supply disruptions.
Operator impact
Healthcare operators including pharmacies, hospitals, and medical suppliers stand to benefit from more unified and intelligent supply chain coordination through AI-driven inventory management and procurement automation. By replacing manual, disconnected purchasing processes with a real-time data network, Aumet enables operators to reduce stockouts, optimize order timing, and improve supplier collaboration.
The platform’s embedded AI supports dynamic decision-making workflows that can improve operational resilience by anticipating demand fluctuations and supply risks. For healthcare buyers and procurement teams, these technological advances reduce overhead and complexity while enhancing their ability to navigate fragmented pharmaceutical supplier ecosystems common to emerging markets.
What to watch next
Expansion efforts will focus on growing market penetration in key GCC countries such as Saudi Arabia, Jordan, Egypt, and Oman, where digital healthcare infrastructure modernization is gathering momentum. Monitoring Aumet’s ability to scale its AI platform and secure critical supply chain partnerships will be key indicators of broader regional digitization progress.
Additionally, attention should be paid to how AI-driven procurement platforms like Aumet evolve to incorporate embedded finance functionalities and enhanced predictive analytics, which can further streamline purchasing workflows and improve working capital management within healthcare supply chains.